Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Countries Covering 107 Million Inhabitants.
Int J Mol Sci
2025
26
17
Increased middle cerebral artery velocity predicts malignant media infarction after endovascular stroke thrombectomy.
Therap Adv Neurol Dis
2025
18
Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
2025
12
1
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
J Neurol Neurosurg Psychiatry
2025
96
11
1046-1052
Beyond oscillations-Toward a richer characterization of brain states.
Imaging Neurosci.
2025
3
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.
Neurol Neuroimmunol Neuroinflamm
2025
12
6
Replication of the 2023 radiologically isolated syndrome criteria in a multi-centre cohort.
Brain Commun
2025
7
5
Assessing the predictive value of peak alpha frequency for the sensitivity to pain.
Pain
2025
166
9
2076-2090
T1-weighted subtraction maps improve the detection of contrast-enhancing lesions in multiple sclerosis.
Eur J Radiol
2026
195